Topics

[Articles] Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

21:33 EDT 13 Sep 2019 | The Lancet

We generated risk models that are robust across cohorts, which adds to their potential clinical applicability. The models could aid clinicians in the interpretation of CSF biomarker and hippocampal volume results in individuals with MCI, and help research and clinical settings to prepare for a future of precision medicine in Alzheimer's disease. Future research should focus on the clinical utility of the models, particularly if their use affects participants' understanding, emotional wellbeing, and behaviour.

Original Article: [Articles] Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

NEXT ARTICLE

More From BioPortfolio on "[Articles] Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study"

Quick Search

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...